Back to search

Article

“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatment

2021-08-23

Abstract excerpt

<h4>Background</h4> Prior to the COVID-19 pandemic, the United States (US) was already facing an epidemic of opioid overdose deaths. Overdose deaths continued to surge during the pandemic. To limit COVID-19 spread and to avoid disruptions in access to medications for opioid use disorder (MOUD), including buprenorphine and methadone, US federal and state agencies granted unprecedented exemptions to existing MOUD gu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb63c904-6f56-5a84-99aa-0d9a0e6983ac
DOI
10.1101/2021.08.20.21262382
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatmentDOI 10.1101/2021.08.20.21262382
Experiences of Opioid Use and Perceptions of Medication-Assisted Treatment (MAT) in Oakland's Safety Net Clinics Amid the COVID-19 PandemicSemantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023Semantic proximity
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: A cross-sectional survey of provider experiencesSemantic proximity
Patient Perspectives on Buprenorphine Treatment for Opioid Use Disorder and Preferences for Long-Acting Injectable Formulations: Findings from a National Online SurveySemantic proximity
COVID-19, Corrections, and Early-Release: Implications and Solutions for Populations with Opioid and Substance Use DisordersSemantic proximity
Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staffSemantic proximity
Opioid Use Disorder Treatment Disruptions during the COVID-19 Pandemic and Other Disasters: A Scoping Review Addressing Dual Public Health EmergenciesSemantic proximity
“There’s absolutely no downside to this, I mean except community opposition:” A qualitative study of the acceptability of vending machines for harm reductionSemantic proximity
Alternative Mental Health Therapies in Prolonged Lockdowns: Narratives from COVID-19Semantic proximity
Barriers and Facilitators to Community Pharmacist-Provided Injectable Naltrexone for Formerly Incarcerated Individuals During Community Reentry in WisconsinSemantic proximity
Does Medicaid Institutions for Mental Diseases Exclusion Waiver Crowd Out the Access to Treatment Among Commercially Insured Substance Use Disorder Patients? An Empirical Study Using Commercial Insurance Claims DataSemantic proximity
Select a neighboring publication to make it the new centre.